The Link Between Autism and Trauma
The millions of Americans with autism and other developmental issues are more vulnerable to emotional trauma, often from bullying or sexual abuse. What can you do if this has happened to someone in your life?
On April 2, 2021, viloxazine, brand name Qelbree, received FDA approval for the treatment of ADHD in children and adolescents ages 6-17 years old. The latest issue of The Carlat Child Psychiatry Report includes a News of Note covering this newly approved medication for ADHD. In this podcast, we discuss the advantages and disadvantages of viloxazine for children and adolescents with ADHD.
https://www.thecarlatreport.com/podcast/viloxazine-qelbree-a-faster-strattera-2/